HCA Healthcare stock steadies near USD 427.71

Published on 09/22/2026 at 09:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock closed at USD 427.71 on September 18, 2026, down 0.31 percent. Q2 FY26 revenue was USD 20.23 billion and EPS was USD 6.85.

HCA, US42225T1079, Illustration mit AI erstellt.

HCA Healthcare stock (ISIN US42225T1079) closed at USD 427.71 on September 18, 2026, down 0.31 percent from the previous close of USD 429.04. The stock also sat inside a 52-week range of USD 353.99 to USD 556.52, while Yahoo Finance showed a market capitalization of USD 112.8 billion at that snapshot.

Q2 numbers still frame the trade

HCA Healthcare reported Q2 FY26 revenue of USD 20.23 billion and diluted EPS of USD 6.85, according to the company figures quoted by ad hoc news. The reported revenue and EPS give investors the current operating base even after the latest close on September 18, 2026.

That quarter remains the most recent reported period in the available data, and it sets the comparison for the next update. The combination of USD 20.23 billion in revenue and USD 6.85 in EPS matters more than the short-term day move because it anchors valuation against the last reported operating run-rate.

Valuation stays restrained

According to ad hoc news, HCA Healthcare stock was cited at USD 427.71 on September 18, 2026, while a market overview on Simply Wall St put its fair value at USD 452.29 on September 21, 2026, down from USD 458.67. That leaves the stock below the updated fair value estimate and keeps the latest move tied to valuation rather than a sharp business rerating.

HCA Healthcare stock ended at USD 427.71 on September 18, 2026, and the closing level remained closer to the middle of its 52-week band than to either extreme. For investors, the key tension is the gap between the latest price and the USD 452.29 fair value cited on September 21, 2026.